Apollon Wealth Management, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1764387 MOUNT PLEASANT, SC

Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$265,415

+$17,648 QoQ

Shares Held

7,834

-4.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#471

of 674 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Apollon Wealth Management, LLC holds $15,358,516 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	22,585	$12,237,230
2	ZTS	Zoetis Inc.	14,109	$1,013,872
3	NBIX	Neurocrine Biosciences Inc	2,568	$432,810
4	VTRS	Viatris Inc	22,397	$355,664
5	LQDA	Liquidia Corp	4,075	$324,899
6	LNTH	Lantheus Holdings, Inc.	2,779	$308,302
7	TEVA	Teva Pharmaceutical Industries Ltd This page	7,834	$265,415
8	HLN	Haleon plc	20,563	$191,852

All Filings in TEVA

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$265,415	7,834	-4.8%	Shares	Sole	2026-07-23
2026-03-31	$247,767	8,226	-68.9%	Shares	Sole	2026-04-22
2023-12-31	$276,023	26,439	+0.2%	Shares	Sole	2024-02-06
2023-09-30	$269,065	26,379	-12.2%	Shares	Sole	2023-11-14
2023-06-30	$226,110	30,028	-0.9%	Shares	Sole	2023-08-04
2023-03-31	$268,270	30,313	+28.3%	Shares	Sole	2023-05-16
2022-12-31	$215,487	23,628	-1.0%	Shares	Sole	2023-02-15
2022-09-30	$192,574	23,863	-0.8%	Shares	Sole	2022-11-08
2022-06-30	$180,953	24,063	+20.7%	Shares	Sole	2022-08-11
2022-03-31	$187,217	19,938	-7.4%	Shares	Sole	2022-05-16
2021-12-31	$172,519	21,538	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.